At Mithridates Therapeutics, we isolate peptides from animal toxins (e.g. snake venom, mosquito saliva) and develop them as therapeutic drugs. Through our venom toxin drug discovery platform, we have identified a set of bioactive peptides, which we have sequence-optimized for enhanced target receptor affinity, selectivity and optimal efficacy.
Company Details
- Employees
- 1
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mithridatestx.com/
- Keywords
- peptides and therapeutics.
Mithridates Therapeutics Questions
Mithridates Therapeutics's website is https://mithridatestx.com/
Mithridates Therapeutics's LinkedIn profile is https://www.linkedin.com/company/mithridatestx
Mithridates Therapeutics has
1 employees.
View email and phone details for 1
employees at Mithridates Therapeutics.
Mithridates Therapeutics's industry is
Biotechnology Research
Mithridates Therapeutics's top competitors are
Polyose Bio,
Primetaz,
Novobeing,
Skip It.,
Nucleate Boston,
Hill Research,
Redpoint Oncology, Inc,
Fourier Llc,
Luminous,
Infocus Therapeutics.
Mithridates Therapeutics's categories are Biotechnology Research
Mithridates Therapeutics's founding year is 2024
